Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1974 Nov;10(5):1068–1071. doi: 10.1128/iai.10.5.1068-1071.1974

Resistance to Mycobacterium leprae in Mice Infected with Toxoplasma gondii and Besnoitia jellisoni

James L Krahenbuhl 1, L Levy 2, J S Remington 3
PMCID: PMC423063  PMID: 16558091

Abstract

Mice chronically infected with the intracellular protozoan Toxoplasma gondii or Besnoitia jellisoni were resistant to footpad challenge with Mycobacterium leprae. Resistance was manifested by lower numbers of recoverable M. leprae in the footpads of protozoal-infected mice and was enhanced in Toxoplasma-infected mice by a booster injection of Toxoplasma antigen in the infected footpad. The results suggest a major role for the activated macrophage in the control of M. leprae infection.

Full text

PDF
1068

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Evans M. J., Levy L. Ultrastructural changes in cells of the mouse footpad infected with Mycobacterium leprae. Infect Immun. 1972 Feb;5(2):238–247. doi: 10.1128/iai.5.2.238-247.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Gaines J. D., Araujo F. G., Krahenbuhl J. L., Remington J. S. Simplified in vitro method for measuring delayed hypersensitivity to latent intracellular infection in man (toxoplasmosis). J Immunol. 1972 Jul;109(1):179–182. [PubMed] [Google Scholar]
  3. Gentry L. O., Remington J. S. Resistance against Cryptococcus conferred by intracellular bacteria and protozoa. J Infect Dis. 1971 Jan;123(1):22–31. doi: 10.1093/infdis/123.1.22. [DOI] [PubMed] [Google Scholar]
  4. Krahenbuhl J. L., Blazkovec A. A., Lysenko M. G. In Vivo and In Vitro Studies of Delayed-Type Hypersensitivity to Toxoplasma gondii in Guinea Pigs. Infect Immun. 1971 Feb;3(2):260–267. doi: 10.1128/iai.3.2.260-267.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Krahenbuhl J. L., Gaines J. D., Remington J. S. Lymphocyte transformation in human toxoplasmosis. J Infect Dis. 1972 Mar;125(3):283–288. doi: 10.1093/infdis/125.3.283. [DOI] [PubMed] [Google Scholar]
  6. Krahenbuhl J. L., Remington J. S. In vitro induction of nonspecific resistance in macrophages by specifically sensitized lymphocytes. Infect Immun. 1971 Oct;4(4):337–343. doi: 10.1128/iai.4.4.337-343.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Krahenbuhl J. L., Remington J. S. The role of activated macrophages in specific and nonspecific cytostasis of tumor cells. J Immunol. 1974 Aug;113(2):507–516. [PubMed] [Google Scholar]
  8. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  9. Levy L. Death of Mycobacterium leprae in mice, and the additional effect of dapsone administration. Proc Soc Exp Biol Med. 1970 Dec;135(3):745–749. doi: 10.3181/00379727-135-35134. [DOI] [PubMed] [Google Scholar]
  10. Levy L. The effect of freezing and storage at -60 degrees C on the viability of Mycobacterium leprae. Cryobiology. 1971 Dec;8(6):574–576. doi: 10.1016/0011-2240(71)90010-1. [DOI] [PubMed] [Google Scholar]
  11. Mackaness G. B., Blanden R. V. Cellular immunity. Prog Allergy. 1967;11:89–140. [PubMed] [Google Scholar]
  12. Mackaness G. B. The influence of immunologically committed lymphoid cells on macrophage activity in vivo. J Exp Med. 1969 May 1;129(5):973–992. doi: 10.1084/jem.129.5.973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. REMINGTON J. S., MELTON M. L., JACOBS L. Induced and spontaneous recurrent parasitemia in chronic infections with avirulent strains of Toxoplasma gondii. J Immunol. 1961 Nov;87:578–581. [PubMed] [Google Scholar]
  14. Remington J. S., Cavanaugh E. N. Isolation of the encysted form of Toxoplasma gondii from human skeletal muscle and brain. N Engl J Med. 1965 Dec 9;273(24):1308–1310. doi: 10.1056/NEJM196512092732404. [DOI] [PubMed] [Google Scholar]
  15. Remington J. S., Krahenbuhl J. L., Mendenhall J. W. A role for activated macrophages in resistance to infection with Toxoplasma. Infect Immun. 1972 Nov;6(5):829–834. doi: 10.1128/iai.6.5.829-834.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Remington J. S., Merigan T. C. Resistance to virus challenge in mice infected with protozoa or bacteria. Proc Soc Exp Biol Med. 1969 Sep;131(4):1184–1188. doi: 10.3181/00379727-131-34066. [DOI] [PubMed] [Google Scholar]
  17. Ruskin J., McIntosh J., Remington J. S. Studies on the mechanisms of resistance to phylogenetically diverse intracellular organisms. J Immunol. 1969 Aug;103(2):252–259. [PubMed] [Google Scholar]
  18. Ruskin J., Remington J. S. Immunity and intracellular infection: resistance to bacteria in mice infected with a protozoan. Science. 1968 Apr 5;160(3823):72–74. doi: 10.1126/science.160.3823.72. [DOI] [PubMed] [Google Scholar]
  19. Shepard C. C., Chang Y. T. Effect of DDS on established infections with Mycobacterium leprae in mice. Int J Lepr Other Mycobact Dis. 1967 Jan-Mar;35(1):52–57. [PubMed] [Google Scholar]
  20. Shepard C. C., Congdon C. C. Increased growth of Mycobacterium leprae in thymectomized-irradiated mice after foot pad inoculation. Int J Lepr Other Mycobact Dis. 1968 Apr-Jun;36(2):224–227. [PubMed] [Google Scholar]
  21. Shepard C. C., McRae D. H. A method for counting acid-fast bacteria. Int J Lepr Other Mycobact Dis. 1968 Jan-Mar;36(1):78–82. [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES